Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transcription factors OCT4, SOX2, and NANOG form the central core of the pluripotency network in embryonic stem cells. OCT4 (octamer-binding transcription factor 4) and SOX2 (SRY-box transcription factor 2) interact synergistically as a heterodimer to regulate target genes, including NANOG, and together maintain stem cell identity. NANOG, belonging to the homeobox protein family, acts downstream to help preserve cells in an undifferentiated state and repress differentiation signals. These factors are not enzymes, receptors, or transporters, but rather master regulators of gene expression critical for both natural embryogenesis and for experimental reprogramming of somatic cells into induced pluripotent stem cells (iPSCs).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Octamer-binding transcription factor 4 (OCT4), SRY-box transcription factor 2 (SOX2), and Homeobox protein NANOG (OCT4, SOX2, NANOG).